I am a clinician and researcher within the Emory Department of Medicine in the Division of Infectious Diseases. I care for patients at the Grady Infectious Disease Program HIV Clinic and on the wards of Grady Memorial Hospital. My primary research focuses on understanding the effects of HIV and antiretroviral medications in different tissues of the body and how this may differ between males and females. I am also involved in many research projects examining HIV-human papillomavirus (HPV) co-infection and its impact on anogenital cancers.
Cecile A. Lahiri, MD, MS
- Infectious Disease
- Infectious Disease
- ABMS Internal Medicine
- Emory University School of Medicine
Education & Training
- Medical School: University of North Carolina @ Chapel Hill, School of Medicine
- Residency: Emory University School of Medicine
Payne JF, Ray R, Watson DG, Delille C, Rimler E, Cleveland J, et al. “Vitamin D insufficiency in diabetic retinopathy”. Endocrine Practice 2011; Sep 22: 1-18, PMID 21940279, PMCID PMC4706181. 2.
Wang K, D’Argenio DZ, Acosta EP, Sheth AN, Delille C, Lennox JL, Kerstner-Wood C, Ofotokun I. “Integrated population pharmacokinetic/viral dynamic modeling of lopinavir/ritonavir in HIV-1 treatment naïve patients”. Clinical Pharmacokinetics 2014 Apr; 53: 361-371. PMID 24311282, PMCID PMC3962720. 3.
Delille CA, Pruett ST, Marconi VC, Lennox JL, Armstrong WS, Ofotokun I, et al. “Effect of protein binding on unbound atazanavir and darunavir cerebrospinal fluid concentrations”. Journal of Clinical Pharmacology 2014, Sep; 54 (9): 1063-1071. PMID 24691856, PMCID PMC4396178. 4.
D’Souza G, Burk RD, Palefsky JM, Massad LS, Strickler HD, WIHS HPV Working Group. “Cervical human papillomavirus testing to triage borderline abnormal pap tests in HIV-coinfected women”. AIDS 2014, July 17; 28: 1696-1698. PMID 25232904, PMCID PMC4196721. 5.
Titanji K, Vunnava A, Sheth AN, Delille C, Lennox JL, Sanford SE, Foster A, Easley KA, Weitzmann MN, Ofotokun I. “Dysregulated B cell expression of RANKL and OPG reflects bone loss in HIV infection”. PLoS Pathogen 2014, Nov 13; 10 (10): e1004497. PMID 25393853, PMCID PMC4231117. 6.
Lahiri CD, Tao S, Sheth AN, Acosta EP, Marconi VC, Armstrong WS, Schinazi RF, Vunnava A, Sanford S, Ofotokun I. “Impact of Protease Inhibitors on Intracellular Concentration of Tenofovir-Diphosphate Among HIV-1 Infected Patients”. AIDS 2015, June 1; 29 (9): 1113-5. PMID 25870991, PMCID PMC4490037. 7.
Lahiri CD, Dugan KB, Xie X, Reimers L, Burk RD, Anastos K, et al. “Oral Lopinavir Use and Human Papillomavirus Infection in HIV-Positive Women”. JAIDS 2015, October 1; 70 (2): e63-6. PMID 26181819, PMCID PMC4573346. 8.
Ofotokun I, Titanji K, Vunnava A, Roser-Page S, Vikulina T, Villinger F, Rogers K, Sheth AN, Lahiri CD, Lennox JL, Weitzmann NM. “Antiretroviral therapy induces a rapid increase in bone resorption that is positively associated with the magnitude of immune reconstitution in HIV infection”. AIDS 2016, January 28; 30 (3): 405-14. PMID 26760232, PMCID PMC4712729. 9.
Lahiri CD, Reed-Walker K, Sheth AN, Acosta EP, Vunnava A, Ofotokun I. “Cerebrospinal Fluid Concentrations of Tenofovir and Emtricitabine in the Setting of HIV-1 Protease Inhibitor-Based Regimens”. Journal of Clinical Pharmacology April 2016; 56 (4): 492-6: PMID 26247878, PMCID PMC4744587. 10.
Ofotokun I, Titanji K, Lahiri CD, Vunnava A, Foster A, Sanford SE, Sheth AN, Lennox JL, Knezevic A, Ward L, Easley KA, Powers P, Weitzmann MN. “A single dose zoledronic acid infusion prevents antiretroviral therapy-induced bone loss in treatment-naïve HIV-infected patients: a Phase IIb Trial”. Clinical Infectious Diseases 2016, Sept 1, 63 (5): 663-71. PMID 27193748. 11.
Duggal P, Vergara C, Thio C, Latanich R, Cox A, Kirk G, Mehta S, Busch M, Murphy E, Villacres M, Peters M, French A, Golub E, Eron J, Lahiri C, Shrestha S, Gustafson D, Young M, Anastos K, Aouizerat B, Kim A, Lauer G, and Thomas D. “Genetic basis for variation in plasma IL-18 levels in persons with chronic hepatitis C virus and human immunodeficiency virus-1 infections”. Genes and Immunity 2017 Mar; 18 (2): 82-7. PMID 28300059, PMC 5408324. 12.
Frank M, Lahiri CD, Nguyen ML, Mehta CC, Mosunjac M, Flowers L. “Factors Associated with Anal High-Grade Squamous Intraepithelial Lesion in HIV Positive Men in a Southern U.S. City”. AIDS Res Hum Retroviruses 2018, July; 34 (7): 598-602. PMID 29607650. 13.
Lahiri CD, Brown NL, Ryan KJ, Acosta EP, Sheth AN, Mehta CC, Ingersoll J, Ofotokun I. HIV RNA persists in rectal tissue despite rapid plasma virologic suppression with dolutegravir-based therapy. AIDS 2018, Sept 24; 32 (15): 2151-9. PMID 30005011.
Lahiri CD, Nguyen ML, Mehta CC, Mosunjac M, Tadros T, Unger ER, Rajeevan MS, Richards J, Ofotokun I, Flowers L. Pilot study of markers for high-grade anal dysplasia in a southern cohort from the Women’s Interagency HIV Study (WIHS). Clinical Infectious Diseases, Accepted February 2019.